P&K Skin Research Center Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Revenue	20,121	17,847	14,843	17,957
Other Revenue	-0	-0	-	-
Revenue	20,121	17,847	14,843	17,957
Revenue Growth (YoY)	29.81%	20.24%	-17.34%	-
Cost of Revenue	10,470	9,409	7,668	6,865
Gross Profit	9,651	8,438	7,175	11,092
Selling, General & Admin	3,799	3,828	3,918	3,428
Research & Development	1,537	1,519	1,357	1,670
Other Operating Expenses	24.26	23.15	29.3	19.82
Operating Expenses	5,812	5,856	5,796	5,452
Operating Income	3,839	2,582	1,379	5,640
Interest Expense	-28.84	-26.49	-32.77	-25.77
Interest & Investment Income	3,512	3,753	3,808	2,215
Currency Exchange Gain (Loss)	0.59	0.86	-0.29	0.03
Other Non Operating Income (Expenses)	-233.01	-224.19	63.36	546.89
EBT Excluding Unusual Items	7,090	6,085	5,217	8,377
Gain (Loss) on Sale of Investments	1,017	712.69	140.01	-185.18
Gain (Loss) on Sale of Assets	-0.31	-0.31	-0	-0.97
Pretax Income	8,107	6,797	5,357	8,190
Income Tax Expense	1,357	1,097	656.54	1,060
Earnings From Continuing Operations	6,750	5,701	4,700	7,130
Minority Interest in Earnings	108.51	115.58	112.75	-
Net Income	6,859	5,816	4,813	7,130
Net Income to Common	6,859	5,816	4,813	7,130
Net Income Growth	46.02%	20.84%	-32.50%	-
Shares Outstanding (Basic)	29	29	30	30
Shares Outstanding (Diluted)	29	29	30	30
Shares Change (YoY)	-3.26%	-3.19%	0.58%	-
EPS (Basic)	237.44	200.32	160.48	239.12
EPS (Diluted)	237.44	200.32	160.48	239.12
EPS Growth	50.95%	24.83%	-32.89%	-
Free Cash Flow	7,163	8,410	4,023	6,277
Free Cash Flow Per Share	247.99	289.65	134.13	210.50
Dividend Per Share	40.000	40.000	30.000	35.000
Dividend Growth	33.33%	33.33%	-14.29%	-
Gross Margin	47.97%	47.28%	48.34%	61.77%
Operating Margin	19.08%	14.47%	9.29%	31.41%
Profit Margin	34.09%	32.59%	32.43%	39.71%
Free Cash Flow Margin	35.60%	47.12%	27.10%	34.96%
EBITDA	5,710	4,431	3,114	7,108
EBITDA Margin	28.38%	24.83%	20.98%	39.59%
D&A For EBITDA	1,871	1,848	1,735	1,468
EBIT	3,839	2,582	1,379	5,640
EBIT Margin	19.08%	14.47%	9.29%	31.41%
Effective Tax Rate	16.73%	16.13%	12.26%	12.95%
Advertising Expenses	-	92.33	123.34	312.82

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.